ELTP News and Press, Elite Pharmaceuticals Inc. From 02/16/21

Conference Call Scheduled for Wednesday, February 17 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced re...

Financials for Third Quarter of Fiscal Year 2021 ended December 31, 2020 will be released on February 16, 2021 NORTHVALE, NJ / ACCESSWIRE / February 10, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generi...

NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, is pleased to announce the hiring of Dr. Jason M. LePree as Vice President of Scientific...

NORTHVALE, NJ / ACCESSWIRE / November 24, 2020 / Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) received inquiries about a recent ANDA approval listing for nifedipine under the company name of Elite Pharma. This ANDA approval is no...

Elite Pharmaceuticals (ELTP): FQ2 GAAP EPS of $0.00.Revenue of $7.4M (+59.8% Y/Y)10QPress Release For further details see: Elite Pharmaceuticals reports FQ2 results

Conference Call Scheduled for Tuesday, November 17 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 16, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced resu...

Financials for Second Quarter of Fiscal Year 2021 ended September 30, 2020 will be released November 16, 2020 NORTHVALE, NJ / ACCESSWIRE / November 11, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche gen...

Elite Pharmaceuticals, Inc. (ELTP) Q1 2021 Earnings Conference Call August 17, 2020 11:30 ET Company Participants Nasrat Hakim - President & Chief Executive Officer Carter Ward - Chief Financial Officer Conference Call Participants Presentation Operator Good morni...

Elite Pharmaceuticals ( OTCQB:ELTP ) : FQ1 GAAP EPS of $0.00. More news on: Elite Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Financials for First Quarter of Fiscal Year 2021 ended June 30, 2020 will be released August 14, 2020 NORTHVALE, NJ / ACCESSWIRE / August 14, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche...